Variant · Snv
GGCX NM_000821.7(GGCX):c.1806C>G (p.Val602=)
CI-VAR-00050701Explore in graph →p.Val602=NM_000821.7:c.1806C>GClinVar 337262 rs143538795
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-06
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260908-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 337262 | Benign | criteria provided, multiple submitters, no conflicts | 2 | Vitamin K-dependent clotting factors, combined deficiency of, type 1; GGCX-related disorder; Uterine corpus endometrial carcinoma; Clear cell carcinoma of kidney; Sarcoma; Hepatocellular carcinoma; Thyroid cancer, nonmedullary, 1 | germline | 5 | Feb 02, 2026 | clinvar |